ArticleBMC cancer2025

Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer-study protocol of the OPTIMA study.

E Russ et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.